ACLA Press Releases

  • ACLA Voices Strong Concern Over MedPAC Proposal to Cut Medicare Reimbursement for Laboratory Services

    September 16, 2011
    For Immediate Release September 16, 2011 Contact: Alan Mertz, 202-637-9466 or amertz@acla.com ACLA Voices Strong Concern Over MedPAC Proposal to Cut Medicare Reimbursement for Laboratory Services We believe that additional reimbursement cuts to clinical laboratories are unsustainable, as they would hit an industry that has nothing left to cut.” Washington DC—The proposal now under consideration by the Medicare Payment Advisory Committee to slash MedicareContinue Reading »...
  • Joint Deficit Committee Urged to Reject Laboratory Cost Sharing

    August 25, 2011
    For Release: August 25, 2011 Contact: Alan Mertz, President, ACLA; 202-637-9466 Joint Deficit Committee Urged to Reject Laboratory Cost Sharing Collecting the fees could cost more than the income received and harm access for beneficiaries says American Clinical Laboratory Association Asking Medicare beneficiaries to pay as much as 20% of the cost of their laboratory tests could cost more than it saves, force manyContinue Reading »...
  • ACLA Launches New Website and Domain Name

    August 24, 2011
    FOR IMMEDIATE RELEASE: AUGUST 24, 2011 CONTACT: ALAN MERTZ amertz@acla.com 202-637-9466 ACLA LAUNCHES NEW WEBSITE AND DOMAIN NAME www.acla.com (Washington, DC) – The American Clinical Laboratory Association (ACLA) launched its newly designed website today. Concurrently with the new website design, the ACLA website domain name will be www.acla.com, and all ACLA staff email addresses will be @acla.com. Both changes, the new website and domainContinue Reading »...
  • ACLA Applauds CMS for Proposed Rule Repealing Physician Signature Requirement Avoiding Disruption of Patient Access to Laboratory Services

    June 30, 2011
    FOR IMMEDIATE RELEASE: JUNE 30, 2011 Contact: Alan Mertz American Clinical Laboratory Association (202) 637-9466 amertz@clinical-labs.org ACLA APPLAUDS CMS FOR PROPOSED RULE REPEALING PHYSICIAN SIGNATURE REQUIREMENT AVOIDING DISRUPTION OF PATIENT ACCESS TO LABORATORY SERVICES Washington DC – The American Clinical Laboratory Association (ACLA) applauds the Centers for Medicare and Medicaid Services (CMS) for issuing a proposed rule rescinding the physician signature requirement for laboratoryContinue Reading »...
  • ACLA and HL7 Announce Approval of First-Ever Electronic Directory of Services (eDOS) Implementation Guide

    June 27, 2011
    Ann Arbor, MI, USA and Washington, DC, USA – The American Clinical Laboratory Association (ACLA) and Health Level Seven® International (HL7®) announce the approval of the first-ever implementation guide in the laboratory industry for a reliable process to deliver a laboratory’s electronic Directory of Service to those providers ordering laboratory services in a meaningful and constructive process. The Version 2 Implementation Guide establishes aContinue Reading »...
  • CMS Delays Enforcement of Medicare Physician Signature Requirement Three Months

    December 21, 2010
    FOR IMMEDIATE RELEASE: DECEMBER 21, 2010 Contact: JoAnne Glisson American Clinical Laboratory Association (202) 637-9466 glisson@clinical-labs.org CMS DELAYS ENFORCEMENT OF MEDICARE PHYSICIAN SIGNATURE REQUIREMENT THREE MONTHS; ACLA VOWS TO WORK WITH CMS TOWARD WORKABLE ALTERNATIVES TO REQUIREMENT TO AVOID DISRUPTION OF PATIENT ACCESS TO LABORATORY SERVICES Washington DC – The American Clinical Laboratory Association (ACLA) appreciates the Centers for Medicare and Medicaid Services’ (CMS)Continue Reading »...
  • ACLA Urges Immediate Action by Congress to Extend Technical Component “Grandfather”

    December 01, 2010
    Washington DC – The American Clinical Laboratory Association (ACLA) today joined nine other health care organizations in sending a letter to the House Ways & Means and Senate Finance Committees’ leadership urging swift action to extend the Technical Component (TC) “Grandfather” set to expire this year on December 31st. The TC “Grandfather” would ensure that hospitals can continue to rely on independent laboratories toContinue Reading »...
  • Clinical Laboratory Industry on Role for FDA in Regulating Laboratory Developed Tests

    July 16, 2010
    July 16, 2010 For Immediate Release Contacts: Alan Mertz, 202-637-9466; amertz@clinical-labs.org David Mongillo, 202-637-9466; dmongillo@clinical-labs.org Clinical Laboratory Industry on Role for FDA in Regulating Laboratory Developed Tests “21st Century tests require 21st Century Solutions” Washington, DC — The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced wayContinue Reading »...
  • ACLA Supports Physician Guidance in Patient-Centered Genetic Testing

    May 12, 2010
    Washington DC – Consumers should seek the guidance of a personal physician or other health care provider in the use of direct to consumer genetic tests to ensure proper understanding of the results and appropriate follow-up, said the American Clinical Laboratory Association (ACLA) today. Recent media reports of genetic tests being marketed and sold directly to consumers in drug stores and other retail establishmentsContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12